ILDR1: A Protein Involved in Many Cellular Processes (G286676)

Target Name: ILDR1

NCBI ID: G286676

ILDR1

ILDR1: A Protein Involved in Many Cellular Processes

ILDR1 (Integrin-like protein 1) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, liver, and pancreas. It is a member of the integrin family, which is a group of transmembrane proteins that play a critical role in cell-cell and cell-extracellular matrix interactions.

ILDR1 is involved in many different cellular processes in the body, including cell adhesion, migration, and the regulation of signaling pathways that control cell behavior. It is also involved in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the main functions of ILDR1 is its role in cell adhesion. ILDR1 is a critical protein for the stickiness of cells to other cells, allowing them to stick together and form tissues. This is important for many different processes in the body, including the development and maintenance of tissues and organs, and the regulation of signaling pathways that control cell behavior.

ILDR1 is also involved in the regulation of signaling pathways that control cell behavior. Many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders, are caused by the misregulation of signaling pathways. ILDR1 plays a critical role in regulating these pathways, ensuring that cells are able to respond properly to stimuli and communicate with one another.

In addition to its role in cell adhesion and signaling pathways, ILDR1 is also involved in the development and progression of many diseases. For example, studies have shown that high levels of ILDR1 are associated with the development of many cancer types, including breast, ovarian, and prostate cancer. Additionally, ILDR1 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

Furthermore, ILDR1 is also involved in the regulation of inflammation. Many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders, are caused by the misregulation of signaling pathways that control the immune system. ILDR1 plays a critical role in regulating these pathways, ensuring that the immune system is able to respond properly to stimuli and protect the body from infection.

In conclusion, ILDR1 is a protein that is involved in many different cellular processes in the body. It is a critical protein for the stickiness of cells to other cells, the regulation of signaling pathways that control cell behavior, the development and progression of many diseases, and the regulation of inflammation. As a drug target and biomarker, ILDR1 has the potential to be a valuable tool in the treatment of many different diseases.

Protein Name: Immunoglobulin Like Domain Containing Receptor 1

Functions: Maintains epithelial barrier function by recruiting MARVELD2/tricellulin to tricellular tight junctions (tTJs) (PubMed:23239027). Crucial for normal hearing by maintaining the structural and functional integrity of tTJs, which are critical for the survival of auditory neurosensory HCs. Mediates fatty acids and lipoproteins-stimulated CCK/cholecystokinin secretion in the small intestine. In the inner ear, may regulate alternative pre-mRNA splicing via binding to TRA2A, TRA2B and SRSF1 (By similarity)

The "ILDR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ILDR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets